Matinas Biopharma Holdings Inc (MTNB) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access MTNB Annual Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Matinas Biopharma Holdings Inc adapts its asset base and funding mix.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent0.76
Cash & Short-term Investments0.00
Other Current Assets0.05
Prepaid Expense And Other Assets Current0.33
Total Current Assets1.14
Equipment/Property/Plant Net0.00
Intangible Assets2.26
Other Assets, Noncurrent0.01
Restricted Cash Current0.05
Restricted Cash Noncurrent0.20
Operating Lease Right Of Use Asset0.46
Finance Lease Right Of Use Asset0.00
Total Assets3.41
Liabilities
Accounts Payable, Current AC0.85
Accrued Liabilities And Other Liabilities0.50
Other Liabilities, Current0.00
Total Current Liabilities1.35
Total Long-term Debt0.00
Other liabilities, Noncurrent0.26
Operating Lease Liability Current0.72
Finance Lease Liability Current0.00
Operating Lease Liability Noncurrent0.46
Finance Lease Liability Noncurrent0.01
Total Liabilities1.61
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock215.83
Retained Earnings / Accumulated Deficit-214.03
Other Equity0.00
Common Stockholder's Equity1.80
Total Stockholder's Equity1.80
Liabilities & Stockholder's Equity3.41
4 historic quarters locked

Sign in to unlock the full Matinas Biopharma Holdings Inc balance sheet history.

About Matinas Biopharma Holdings Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 13, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-037748

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.